CCM
Compton Capital Management Portfolio holdings
AUM
$4.32M
Turnover
83.33%
1-Year Est. Return
27.38%
This Fund
S&P 500
This Quarter
Est. Return
+5.98%
1 Year Est. Return
+27.38%
3 Year Est. Return
+75.57%
5 Year Est. Return
+123.58%
10 Year Est. Return
+303.58%
AUM
$204M
AUM Growth
+$12.5M
(+6.5%)
Cap. Flow
+$2.64M
Cap. Flow
% of AUM
1.3%
Top 10 Holdings %
Top 10 Hldgs %
31.85%
Holding
152
New
15
Increased
58
Reduced
46
Closed
10
Avg Time Held
2.9
years
Top 10 Avg Time Held
3.3
years
Top 20 Avg Time Held
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$994K |
| 2 |
LGF.A
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
|
+$679K |
| 3 |
PIV
PWSHS S&P 500 HIGH QTY PORTF S&P HIGH QTY RKGS INDEX
PIV
|
+$437K |
| 4 |
Salesforce
CRM
|
+$423K |
| 5 |
Invesco QQQ Trust
QQQ
|
+$295K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$619K |
| 2 |
MON
Monsanto Co
MON
|
+$545K |
| 3 |
Norfolk Southern
NSC
|
+$530K |
| 4 |
Invesco Preferred ETF
PGX
|
+$411K |
| 5 |
Unilever NV New York Registry Shares
UN
|
+$386K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.94% |
| 2 | Technology | 17.12% |
| 3 | Financials | 14.83% |
| 4 | Industrials | 12.94% |
| 5 | Communication Services | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Zimmer Biomet
ZBH
$17.5B
| $392K | 0.19% |
3,309
+80
| +2% | +$9.07K |
2013 Q2
15 quarters
|
|
102
Phillips 66
PSX
$119B
| $387K | 0.19% |
4,888
-50
| -1% | -$4.03K |
2013 Q2
15 quarters
|
|
103
Duke Energy
DUK
$93.3B
| $382K | 0.19% |
4,659
| – | – |
2013 Q2
15 quarters
|
|
104
DELISTED
Du Pont De Nemours E I
DD
| $366K | 0.18% |
4,560
-150
| -3% | -$11.6K |
2013 Q2
15 quarters
|
|
105
DELISTED
Walgreens Boots Alliance
WBA
| $326K | 0.16% |
3,928
+62
| +2% | +$5.2K |
2013 Q3
14 quarters
|
|
106
DELISTED
Gramercy Property Trust
GPT
| $315K | 0.15% |
11,961
-1
| -0% | -$27 |
2013 Q2
15 quarters
|
|
107
Bank of New York Mellon
BNY
$93.4B
| $311K | 0.15% |
6,579
| – | – |
2013 Q2
15 quarters
|
|
|
108
Invesco QQQ Trust
QQQ
$488B
| $306K | 0.15% |
+2,311
| New | +$295K |
2017 Q1
0 quarters
|
|
109
iShares MSCI Emerging Markets ETF
EEM
$29.8B
| $305K | 0.15% |
7,735
+300
| +4% | +$11.4K |
2013 Q2
15 quarters
|
|
110
Marathon Petroleum
MPC
$136B
| $303K | 0.15% |
5,990
| – | – |
2013 Q4
13 quarters
|
|
111
BP
BP
$126B
| $302K | 0.15% |
10,028
-264
| -3% | -$8.03K |
2013 Q2
15 quarters
|
|
112
Varex Imaging
VREX
$781M
| $301K | 0.15% |
+8,944
| New | +$283K |
2017 Q1
0 quarters
|
|
113
Roper Technologies
ROP
$36.9B
| $299K | 0.15% |
1,450
| – | – |
2014 Q4
9 quarters
|
|
114
Apollo Global Management
APO
$67B
| $293K | 0.14% |
12,050
| – | – |
2014 Q2
11 quarters
|
|
115
Oracle
ORCL
$396B
| $288K | 0.14% |
6,447
-1,503
| -19% | -$62.6K |
2013 Q2
15 quarters
|
|
116
KKR & Co
KKR
$76.8B
| $280K | 0.14% |
15,373
+173
| +1% | +$3.07K |
2013 Q2
15 quarters
|
|
117
GSK
GSK
$95.9B
| $277K | 0.14% |
5,248
| – | – |
2015 Q4
5 quarters
|
|
|
RDS.A
118
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $272K | 0.13% |
+5,255
| New | +$274K |
2017 Q1
0 quarters
|
|
119
Elevance Health
ELV
$92.8B
| $269K | 0.13% |
1,625
| – | – |
2014 Q1
12 quarters
|
|
120
Invesco S&P MidCap Low Volatility ETF
XMLV
$699M
| $268K | 0.13% |
+6,325
| New | +$264K |
2017 Q1
0 quarters
|
|
121
State Street Utilities Select Sector SPDR ETF
XLU
$24.2B
| $267K | 0.13% |
10,400
| – | – |
2013 Q2
15 quarters
|
|
122
Fluor
FLR
$6.37B
| $263K | 0.13% |
5,000
+1,100
| +28% | +$60K |
2015 Q4
5 quarters
|
|
123
SPDR Gold Trust
GLD
$139B
| $254K | 0.12% |
2,142
| – | – |
2013 Q2
15 quarters
|
|
124
Southern Company
SO
$103B
| $246K | 0.12% |
4,947
-99
| -2% | -$4.89K |
2013 Q2
15 quarters
|
|
125
JetBlue
JBLU
$1.14B
| $244K | 0.12% |
11,818
+2,508
| +27% | +$51.1K |
2016 Q4
1 quarter
|
|
Similar funds
GPCM
MAM
BGCI
CAM
EAM
SM
TPL
RC
Compton Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Compton Capital Management held 152 positions worth $204M, up 6.5% from $191M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Compton Capital Management's Q1 2017 filing shows 15 new, 58 increased, 46 reduced and 10 closed positions. Its largest new stake was Accenture: 8,323 shares worth $998K. The largest sale was St Jude Medical, an estimated $619K.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Financials.
- Compton Capital Management's largest Q1 2017 buy was Accenture: 8,323 shares worth $998K.
- Compton Capital Management added most to Abbott in Q1 2017, an estimated $290K increase.
- Compton Capital Management's biggest Q1 2017 reduction was Invesco Preferred ETF, cutting an estimated $411K.
- Compton Capital Management fully exited St Jude Medical in Q1 2017, selling an estimated $619K.
- Compton Capital Management's ten largest holdings make up 32% of its $204M portfolio in Q1 2017.
- Compton Capital Management opened 15 new positions and closed 10 in Q1 2017.
- Compton Capital Management's portfolio value rose 6.5% quarter-over-quarter to $204M.
Based on Compton Capital Management's 13F filing for Q1 2017, filed 9 May 2017.